Inspire Medical Systems (INSP) Competitors

$44.82 -0.75 (-1.64%)

As of 10:38 AM Eastern

INSP vs. BLCO, STVN, NVST, IRTC, and TMDX

Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Bausch + Lomb (BLCO), Stevanato Group (STVN), Envista (NVST), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.

How does Inspire Medical Systems compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

: Inspire Medical Systems has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bausch + Lomb $5.10B 1.10 -$360M -$0.62 N/A
Inspire Medical Systems $911.98M 1.42 $145.42M $4.98 9.00
: Inspire Medical Systems has a net margin of 14.33% compared to Bausch + Lomb's net margin of -4.21%. Inspire Medical Systems' return on equity of 10.35% beat Bausch + Lomb's return on equity.
Company Net Margins Return on Equity Return on Assets
Bausch + Lomb -4.21% 3.60% 1.69%
Inspire Medical Systems 14.33% 10.35% 8.81%
: Bausch + Lomb currently has a consensus target price of $18.08, suggesting a potential upside of 14.49%. Inspire Medical Systems has a consensus target price of $85.00, suggesting a potential upside of 89.63%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Bausch + Lomb.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
9 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.21
Inspire Medical Systems
1 Sell rating(s)

15 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.15
: 11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: In the previous week, Inspire Medical Systems had 26 more articles in the media than Bausch + Lomb. MarketBeat recorded 39 mentions for Inspire Medical Systems and 13 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 1.06 beat Inspire Medical Systems' score of 0.64 indicating that Bausch + Lomb is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
18 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
: Bausch + Lomb has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.10	-$360M	-$0.62	N/A
Inspire Medical Systems	$911.98M	1.42	$145.42M	$4.98	9.00

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-4.21%	3.60%	1.69%
Inspire Medical Systems	14.33%	10.35%	8.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
Inspire Medical Systems	1 Sell rating(s)	15 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.15

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspire Medical Systems	18 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Inspire Medical Systems beats Bausch + Lomb on 12 of the 15 factors compared between the two stocks.

How does Inspire Medical Systems compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

: Inspire Medical Systems has a net margin of 14.33% compared to Stevanato Group's net margin of 11.83%. Stevanato Group's return on equity of 10.44% beat Inspire Medical Systems' return on equity.
Company Net Margins Return on Equity Return on Assets
Stevanato Group 11.83% 10.44% 6.22%
Inspire Medical Systems 14.33% 10.35% 8.81%
: In the previous week, Inspire Medical Systems had 27 more articles in the media than Stevanato Group. MarketBeat recorded 39 mentions for Inspire Medical Systems and 12 mentions for Stevanato Group. Inspire Medical Systems' average media sentiment score of 0.64 beat Stevanato Group's score of 0.44 indicating that Inspire Medical Systems is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
4 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
18 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
: Inspire Medical Systems has a consensus target price of $85.00, suggesting a potential upside of 89.63%. Given Inspire Medical Systems' higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Stevanato Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
1 Sell rating(s)
1 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.40
Inspire Medical Systems
1 Sell rating(s)

15 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.15
: Stevanato Group has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500.
: Stevanato Group has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Stevanato Group €1.34B 4.13 €158.21M €0.58 31.57
Inspire Medical Systems $911.98M 1.42 $145.42M $4.98 9.00
: 94.9% of Inspire Medical Systems shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.83%	10.44%	6.22%
Inspire Medical Systems	14.33%	10.35%	8.81%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspire Medical Systems	18 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Inspire Medical Systems	1 Sell rating(s)	15 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.15

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.13	€158.21M	€0.58	31.57
Inspire Medical Systems	$911.98M	1.42	$145.42M	$4.98	9.00

Summary

Inspire Medical Systems beats Stevanato Group on 10 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Envista?

Inspire Medical Systems (NYSE:INSP) and Envista (NYSE:NVST) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

: Inspire Medical Systems has a net margin of 14.33% compared to Envista's net margin of 2.41%. Inspire Medical Systems' return on equity of 10.35% beat Envista's return on equity.
Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems 14.33% 10.35% 8.81%
Envista 2.41% 7.09% 3.90%
: 94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: In the previous week, Inspire Medical Systems had 19 more articles in the media than Envista. MarketBeat recorded 39 mentions for Inspire Medical Systems and 20 mentions for Envista. Inspire Medical Systems' average media sentiment score of 0.64 beat Envista's score of 0.54 indicating that Inspire Medical Systems is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
18 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
3 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Inspire Medical Systems has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Envista has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.
: Inspire Medical Systems presently has a consensus target price of $85.00, suggesting a potential upside of 89.63%. Envista has a consensus target price of $28.83, suggesting a potential upside of 18.40%. Given Inspire Medical Systems' higher possible upside, equities analysts plainly believe Inspire Medical Systems is more favorable than Envista.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
1 Sell rating(s)
15 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.15
Envista
0 Sell rating(s)

9 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.40
: Inspire Medical Systems has higher earnings, but lower revenue than Envista. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inspire Medical Systems $911.98M 1.42 $145.42M $4.98 9.00
Envista $2.72B 1.46 $47M $0.28 86.97

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	14.33%	10.35%	8.81%
Envista	2.41%	7.09%	3.90%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	18 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	3 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	1 Sell rating(s)	15 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.15
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$911.98M	1.42	$145.42M	$4.98	9.00
Envista	$2.72B	1.46	$47M	$0.28	86.97

Summary

Inspire Medical Systems beats Envista on 10 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

: Inspire Medical Systems has a net margin of 14.33% compared to iRhythm Technologies' net margin of -3.53%. Inspire Medical Systems' return on equity of 10.35% beat iRhythm Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
iRhythm Technologies -3.53% -10.26% -1.39%
Inspire Medical Systems 14.33% 10.35% 8.81%
: In the previous week, Inspire Medical Systems had 18 more articles in the media than iRhythm Technologies. MarketBeat recorded 39 mentions for Inspire Medical Systems and 21 mentions for iRhythm Technologies. Inspire Medical Systems' average media sentiment score of 0.64 beat iRhythm Technologies' score of 0.52 indicating that Inspire Medical Systems is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
7 Very Positive mention(s)
6 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
18 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
: Inspire Medical Systems has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
iRhythm Technologies $787.85M 5.06 -$44.55M -$0.86 N/A
Inspire Medical Systems $911.98M 1.42 $145.42M $4.98 9.00
: 94.9% of Inspire Medical Systems shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: iRhythm Technologies currently has a consensus target price of $193.38, suggesting a potential upside of 59.48%. Inspire Medical Systems has a consensus target price of $85.00, suggesting a potential upside of 89.63%. Given Inspire Medical Systems' higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than iRhythm Technologies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)

11 Buy rating(s)

2 Strong Buy rating(s)
2.93
Inspire Medical Systems
1 Sell rating(s)

15 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.15
: iRhythm Technologies has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Inspire Medical Systems	14.33%	10.35%	8.81%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	7 Very Positive mention(s)	6 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspire Medical Systems	18 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$787.85M	5.06	-$44.55M	-$0.86	N/A
Inspire Medical Systems	$911.98M	1.42	$145.42M	$4.98	9.00

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93
Inspire Medical Systems	1 Sell rating(s)	15 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.15

Summary

Inspire Medical Systems beats iRhythm Technologies on 12 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to TransMedics Group?

Inspire Medical Systems (NYSE:INSP) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

: Inspire Medical Systems currently has a consensus price target of $85.00, suggesting a potential upside of 89.63%. TransMedics Group has a consensus price target of $135.00, suggesting a potential upside of 96.15%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts plainly believe TransMedics Group is more favorable than Inspire Medical Systems.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
1 Sell rating(s)
15 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.15
TransMedics Group
0 Sell rating(s)

6 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.50
: 94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by insiders. Comparatively, 6.9% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: In the previous week, Inspire Medical Systems had 8 more articles in the media than TransMedics Group. MarketBeat recorded 39 mentions for Inspire Medical Systems and 31 mentions for TransMedics Group. Inspire Medical Systems' average media sentiment score of 0.64 beat TransMedics Group's score of -0.35 indicating that Inspire Medical Systems is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
18 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
TransMedics Group
4 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
8 Negative mention(s)
1 Very Negative mention(s)
Neutral
: TransMedics Group has a net margin of 27.04% compared to Inspire Medical Systems' net margin of 14.33%. TransMedics Group's return on equity of 22.38% beat Inspire Medical Systems' return on equity.
Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems 14.33% 10.35% 8.81%
TransMedics Group 27.04% 22.38% 8.46%
: Inspire Medical Systems has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500.
: TransMedics Group has lower revenue, but higher earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Inspire Medical Systems $911.98M 1.42 $145.42M $4.98 9.00
TransMedics Group $605.49M 3.93 $190.29M $4.90 14.05

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	1 Sell rating(s)	15 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.15
TransMedics Group	0 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	18 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	4 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	8 Negative mention(s)	1 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	14.33%	10.35%	8.81%
TransMedics Group	27.04%	22.38%	8.46%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$911.98M	1.42	$145.42M	$4.98	9.00
TransMedics Group	$605.49M	3.93	$190.29M	$4.90	14.05

Summary

TransMedics Group beats Inspire Medical Systems on 11 of the 16 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INSP vs. The Competition

Export

Metric	Inspire Medical Systems	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$1.29B	$1.46B	$6.20B	$22.89B
Dividend Yield	N/A	N/A	2.78%	4.01%
P/E Ratio	9.95	61.35	28.72	28.15
Price / Sales	1.42	5.93	529.04	23.31
Price / Cash	15.96	24.05	43.30	25.49
Price / Book	1.63	4.83	9.85	4.63
Net Income	$145.42M	-$54.60M	$3.55B	$1.07B
7 Day Performance	N/A	N/A	N/A	-0.69%
1 Month Performance	-15.98%	7.91%	4.55%	4.01%
1 Year Performance	-70.56%	0.90%	40.01%	28.49%

Inspire Medical Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INSP Inspire Medical Systems	4.6517 of 5 stars	$44.82 -1.6%	$85.00 +89.6%	-71.0%	$1.29B	$911.98M	9.95	1,333	Earnings Report Analyst Forecast
BLCO Bausch + Lomb	4.4638 of 5 stars	$15.89 +0.4%	$18.25 +14.9%	+40.0%	$5.64B	$5.10B	N/A	13,000	Analyst Revision
STVN Stevanato Group	2.9739 of 5 stars	€16.13 -0.3%	N/A	-17.3%	€4.88B	€1.19B	27.81	6,010	News Coverage Earnings Report
NVST Envista	2.3028 of 5 stars	$26.77 -0.1%	$27.85 +4.0%	+45.0%	$4.37B	$2.72B	95.62	12,000	News Coverage Earnings Report Analyst Forecast
IRTC iRhythm Technologies	3.594 of 5 stars	$125.96 +3.0%	$202.92 +61.1%	-8.4%	$4.02B	$747.14M	N/A	2,400

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:INSP) was last updated on 5/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inspire Medical Systems (INSP) Competitors

INSP vs. BLCO, STVN, NVST, IRTC, and TMDX

How does Inspire Medical Systems compare to Bausch + Lomb?

Summary

How does Inspire Medical Systems compare to Stevanato Group?

Summary

How does Inspire Medical Systems compare to Envista?

Summary

How does Inspire Medical Systems compare to iRhythm Technologies?

Summary

How does Inspire Medical Systems compare to TransMedics Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INSP vs. The Competition

Inspire Medical Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inspire Medical Systems (INSP) Competitors

INSP vs. BLCO, STVN, NVST, IRTC, and TMDX

How does Inspire Medical Systems compare to Bausch + Lomb?

Summary

How does Inspire Medical Systems compare to Stevanato Group?

Summary

How does Inspire Medical Systems compare to Envista?

Summary

How does Inspire Medical Systems compare to iRhythm Technologies?

Summary

How does Inspire Medical Systems compare to TransMedics Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INSP vs. The Competition

Inspire Medical Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools